搜尋結果
US FDA approves Neurocrine Biosciences' movement disorder drug
Reuters· 8 小時前, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the
Morning Bid: Fed QT taper calms the horses, yen pops again
Reuters· 9 小時前Anxious bond traders seem to have taken solace from the Federal Reserve's surprisingly ... ...
South Korea raises diplomatic alert levels citing North Korea threats
Reuters· 10 小時前South Korea's foreign ministry on Thursday raised the terrorism alert level for five ...
U.S. accuses Russia of using chemical weapons in Ukraine, in breach of global ban
CNBC· 11 小時前Servicemen of the National Guard of Ukraine undergo training to storm enemy trenches using ...
Russia breached global chemical weapons ban in Ukraine war, US says
Reuters· 23 小時前The United States on Wednesday accused Russia of violating the international chemical ... ...
From Referee To Investor: Natasha Camy’s Journey To Owning A BAL Team
Forbes· 2 日前... long enough knows officiating is a thankless job. In basketball, referees have< ... ...
Jim Cramer says interest rate worries helped bring on Tuesday's end of April sell off
CNBC· 2 日前After a generally rough April, CNBC's Jim Cramer parsed Tuesday's market action, ...
Angels turn to Tyler Anderson in encounter vs. Phillies
Reuters· 2 日前Cole Tucker may not be the answer to all of the difficulties facing the< ...
US Election 2024-The Daily Rundown
Bastillepost· 2 日前Here’s a rundown of the AP’s latest Election 2024 coverage plans, including live video and text ...
A viral conspiracy theory on TikTok says nice people don’t get promoted. But experts disagree
CNBC· 3 日前One viral TikTok has young workers up in arms about the perils of being pleasant in the</ ...